Please login to the form below

Not currently logged in
Email:
Password:

Lilly names head of corporate business development

Promotion for Darren Carroll
Darren Carroll Lilly

Lilly has promoted Darren Carroll to senior VP of corporate business development.

Carroll most recently held the role of VP of corporate business development since 2010 and has been at Lilly for 18 years. During his career at the company, Carroll has helped lead and create new business models for the firm including e-Lilly, InnoCentive, Lilly Ventures and Lilly Asia Ventures.

Commenting on the work involved in his new role, Carroll said: “Our long term commitment to scientific excellence at Lilly is the foundation for success in identifying, accessing and shaping external innovation.

“It has been recognised by partners that range from start-ups to other top 10 pharmaceutical companies, and it is a critical reason why we are attractive as a partner. We are 'all in' on innovation.”

Carroll also played a key role in driving the firm's Capital Funds Portfolio strategy with multiple venture capital fund managers, which has led to the creation of eleven new companies to date. This includes Artaeus, which Lilly acquired in January 2014.

Derica Rice, executive VP of global services and CFO at Lilly, added: “Darren is the ideal candidate to lead this important and increasingly competitive work. He is a pragmatic, creative individual with an extraordinary bandwidth for managing and understanding complex business opportunities.

“Darren's high integrity, insights into diverse markets and cultures and unique experiences, both inside and outside of Lilly, are important assets as we seek to be more attractive to potential partners.”

6th January 2015

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics